Presidio Pharmaceuticals, Inc.

Management

Omar K. Haffar, Ph.D., Founder, President & Chief Executive Officer: Over 20 years vaccines and antiviral drug development experience; Managing Director, Global Solutions for Infectious Diseases; Founder & CEO, International Therapeutics Inc.; Founder & VP of Infectious Diseases, Cytokine Networks, Inc.; Senior Investigator, Bristol-Myers Squibb; Postdoctoral Fellow, Genentech.

Marcus Conant, M.D., Chief Medical Officer: 25 years experience treating HIV/AIDS patients. Clinician at UCSF and in private practice, and PI on over a dozen HIV clinical trials.

Richard Colonno, Ph.D., Chief Scientific Officer: Over 25 years experience in virology and drug discovery and development; VP, Infectious Disease Drug Discovery, Bristol-Myers Squibb; Senior Director, Antiviral Research, Merck Sharp & Dohme Research Labs; Research Scientist, DuPont; Research Fellow, Roche Institute of Molecular Biology.

Leo Redmond, MBA, Chief Financial Officer: 20 years of financial experience, including supporting R&D, commercial, administrative, and business development groups; Director of Finance at Genentech, Inc.; CFO and Secretary for the Genentech Foundation for Biomedical Sciences.

David V. Jobes, Ph.D., Founder, Vice President of Business Development: Associate Director at VaxGen, Inc.; Sr. Scientist at Applied Biosystems; Founder & COO BioGenysis; Research Fellow at National Institutes of Health (NIH).

	Management \| Board of Directors \| Clinical & Science Advisory Board
	Management Omar K. Haffar, Ph.D., Founder, President & Chief Executive Officer: Over 20 years vaccines and antiviral drug development experience; Managing Director, Global Solutions for Infectious Diseases; Founder & CEO, International Therapeutics Inc.; Founder & VP of Infectious Diseases, Cytokine Networks, Inc.; Senior Investigator, Bristol-Myers Squibb; Postdoctoral Fellow, Genentech. Marcus Conant, M.D., Chief Medical Officer: 25 years experience treating HIV/AIDS patients. Clinician at UCSF and in private practice, and PI on over a dozen HIV clinical trials. Richard Colonno, Ph.D., Chief Scientific Officer: Over 25 years experience in virology and drug discovery and development; VP, Infectious Disease Drug Discovery, Bristol-Myers Squibb; Senior Director, Antiviral Research, Merck Sharp & Dohme Research Labs; Research Scientist, DuPont; Research Fellow, Roche Institute of Molecular Biology. Leo Redmond, MBA, Chief Financial Officer: 20 years of financial experience, including supporting R&D, commercial, administrative, and business development groups; Director of Finance at Genentech, Inc.; CFO and Secretary for the Genentech Foundation for Biomedical Sciences. David V. Jobes, Ph.D., Founder, Vice President of Business Development: Associate Director at VaxGen, Inc.; Sr. Scientist at Applied Biosystems; Founder & COO BioGenysis; Research Fellow at National Institutes of Health (NIH).